NCT00004939View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 31, 1996

Study Completion Date

August 31, 1996

Conditions
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Interventions
DRUG

,4-diaminopyridine

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

National Center for Research Resources (NCRR)

NIH